دورة المؤشرنت للتحليل الفني
50 دينار كويتي
أنت تستخدم أحد المتصفحات القديمة. قد لا يتم عرض هذا الموقع أو المواقع الأخرى بشكل صحيح.
يجب عليك ترقية متصفحك أو استخدام أحد المتصفحات البديلة.
يجب عليك ترقية متصفحك أو استخدام أحد المتصفحات البديلة.
Rnvs
- بادئ الموضوع ka3000
- تاريخ البدء
abuabdulla
عضو نشط
AstraZeneca licensed the drug from Renovis (RNVS - commentary - Cramer's Take - Rating), whose stock collapsed to $3.75, plunging $10.45, or 74%.
With 90 minutes left in the trading day, more than 36 million shares in Renovis had changed hands -- nearly 100 times the normal volume. The average daily volume for the South San Francisco, Calif., biotech company is just above 382,000 shares
الاعلان عن الانتهاء من الدراسة للدواء
26/10/2006
بوعبداللة
With 90 minutes left in the trading day, more than 36 million shares in Renovis had changed hands -- nearly 100 times the normal volume. The average daily volume for the South San Francisco, Calif., biotech company is just above 382,000 shares
الاعلان عن الانتهاء من الدراسة للدواء
26/10/2006
بوعبداللة
abuabdulla
عضو نشط
announced an agreement with Pfizer Inc. (PFE : Pfizer Inc
3:45am 04/11/2007
PFE26.00, ) to extend the term of the companies' collaboration to research, develop and commercialize small molecules that target the vanilloid receptor, VR1. Under the terms of the extension, Pfizer will continue to fund all aspects of the collaboration through June 30, 2008. Other terms of the deal have not been changed. Renovis also said it now expects 2007 contract revenue from existing agreements of $5.3 million to $9.8 million, and total operating expenses of $28 million to $32 million, excluding certain items.
اتفاق جديد للتمويل للبحث
ممكن انجوف طلوع شوي شوي
بوعبدالله
3:45am 04/11/2007
PFE26.00, ) to extend the term of the companies' collaboration to research, develop and commercialize small molecules that target the vanilloid receptor, VR1. Under the terms of the extension, Pfizer will continue to fund all aspects of the collaboration through June 30, 2008. Other terms of the deal have not been changed. Renovis also said it now expects 2007 contract revenue from existing agreements of $5.3 million to $9.8 million, and total operating expenses of $28 million to $32 million, excluding certain items.
اتفاق جديد للتمويل للبحث
ممكن انجوف طلوع شوي شوي
بوعبدالله
دورة المؤشرنت للتحليل الفني
50 دينار كويتي